Immunic, Inc. (IMUX) Insider Trading Activity — Form 4 Filings

Recent IMUX insider trading activity from SEC Form 4 filings, including executive and director buys, sells, awards, filing dates, and data limitations.

Direct answer: Immunic, Inc. (IMUX) has more buying than selling in the recent Form 4 activity available here. The data includes 8 parsed transactions from SEC filings.

SEC data retrieved Sep 17, 2026, 6:55 PM UTC.

Immunic, Inc. insider activity summary

Recent activity includes 8 open-market buys, 0 sells, and other Form 4 transactions. Buy and sell counts summarize the available recent filings; they are not a complete measure of insider conviction.

Cluster-buy signal: at least three open-market purchases occurred within a 14-day window in the available history. This is a screening signal, not a prediction.

Recent Form 4 transactions

Date	Insider	Type	Reported value
Jun 5, 2025	Tardio Jason	BUY	$9,884
Jun 5, 2025	Neermann Joerg	BUY	$22,800
Jun 4, 2025	Neermann Joerg	BUY	$53,900
Jun 3, 2025	Rudick Richard Alan	BUY	$100,024
Nov 12, 2024	Rudick Richard Alan	BUY	$100,369
Nov 7, 2022	Whaley Glenn	BUY	$7,475
Jun 3, 2022	Whaley Glenn	BUY	$10,658
May 12, 2022	Whaley Glenn	BUY	$15,240

Sources and limitations

Source: SEC EDGAR Form 4 filings. Filing data can be delayed, amended, incomplete, or affected by SEC rate limits. Scheduled sales, awards, exercises, and open-market trades have different meanings. This page is informational and is not financial advice.

Showing partial data — 58 of 100 filings could not be fetched due to SEC rate limiting.

Frequently asked questions

When was IMUX insider data retrieved?

Sep 17, 2026, 6:55 PM UTC.

Does insider buying guarantee a higher stock price?

No. Insider transactions are one data point and do not predict future returns.

View the full IMUX stock analysis · Search another ticker's Form 4 filings

The information on this page is for educational and informational purposes only and does not constitute professional financial advice.